SCHEMBL13628956

SCHEMBL13628956

CC(C)NOC(CN(C)c1ccccn1)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.37
CYP2C19 P33261 2/20 0.37
CHRM2 P08172 3/20 0.36
SLC6A4 P31645 3/20 0.36
SLC6A2 P23975 2/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
HTR2A P28223 3/20 0.35
HRH1 P35367 3/20 0.35
ADRA2A P08913 2/20 0.35
DRD1 P21728 2/20 0.35
SLC6A3 Q01959 2/20 0.35
KCNH2 Q12809 2/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
ADRA1A P35348 1/20 0.35
OPRK1 P41145 1/20 0.35
PPARG P37231 3/20 0.35
LMNA P02545 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13628513 0.86 CYP2D6 (0.39) CYP2D6CYP2C19CHRM2SLC6A4SLC6A2
SCHEMBL13628673 0.84 ASIC3 (0.32) ADRA2AADRA2BADRA2CAOC3
SCHEMBL291511 0.77 PPARG (0.41) CYP2D6CYP2C19PPARGLMNAKDM4E
SCHEMBL13628670 0.74 CYP1A2 (0.46) CYP2C19SLC6A4SLC6A2HRH1LMNA
SCHEMBL5779464 0.73 CYP2D6 (0.50) CYP2D6CYP2C19CHRM2SLC6A4SLC6A2
SCHEMBL13628672 0.73 CYP2D6 (0.55) CYP2D6CYP2C19KDM4ESMN1; SMN2GAA
SCHEMBL4339397 0.73 AOC3 (0.53) CYP2D6CYP2C19CHRM2SLC6A4SLC6A2
SCHEMBL13628675 0.72 MAPT (0.46) CYP2D6CYP2C19CHRM2SLC6A4SLC6A2
SCHEMBL14224120 0.69 TACR1 (0.43) LMNAALDH1A1KMT2AMEN1
SCHEMBL28987136 0.66 TSHR (0.50) CYP2D6CYP2C19CHRM2SLC6A4SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612197-B2 Reacting a nucleophil with OH group with an electrophil to form an adduct, reacting adduct with a reagent selected from oxidizing, sulfurizing or selenizing agents to produce hydroxy protected oligonucleotide, heating to deprotect hydroxy protecting group such as 2-(2-pyridyl)aminoethoxycarbonyl The United States of America as repesented by the Secretary of the Department of Health and Human Services (US) 2009-11-03 US disclosed